ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 20 filers reported holding ANI PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $112,000 | -21.1% | 100,000 | -20.0% | 0.00% | -33.3% |
| Q4 2017 | $142,000 | -98.9% | 125,000 | 0.0% | 0.00% | -98.9% |
| Q3 2017 | $13,367,000 | +10182.3% | 125,000 | 0.0% | 0.26% | +8633.3% |
| Q2 2017 | $130,000 | +1.6% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $128,000 | -8.6% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $140,000 | -7.9% | 125,000 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $152,000 | +14.3% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $133,000 | +19.8% | 125,000 | 0.0% | 0.00% | +33.3% |
| Q1 2016 | $111,000 | – | 125,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 9,000,000 | $10,149,000 | 12.63% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 29,751,000 | $33,847,000 | 2.02% |
| Wellesley Asset Management | 25,925 | $29,366,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 18,779 | $21,455,000 | 1.38% |
| Perceptive Advisors | 7,500,000 | $8,458,000 | 0.22% |
| OAKTREE CAPITAL MANAGEMENT LP | 6,857,000 | $7,767,000 | 0.11% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,975,000 | $6,769,000 | 0.09% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,718,000 | $1,945,000 | 0.06% |
| CAMDEN ASSET MANAGEMENT L P /CA | 930,000 | $1,049,000 | 0.03% |
| GABELLI FUNDS LLC | 1,750,000 | $1,983,000 | 0.01% |